Your browser doesn't support javascript.
loading
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.
Suksanpaisan, Lukkana; Xu, Rong; Tesfay, Mulu Z; Bomidi, Carolyn; Hamm, Stefan; Vandergaast, Rianna; Jenks, Nathan; Steele, Michael B; Ota-Setlik, Ayuko; Akhtar, Hinna; Luckay, Amara; Nowak, Rebecca; Peng, Kah Whye; Eldridge, John H; Clarke, David K; Russell, Stephen J; Diaz, Rosa Maria.
Afiliação
  • Suksanpaisan L; Imanis Life Sciences, Rochester, MN 55902, USA.
  • Xu R; Profectus Biosciences, Inc., Pearl River, NY 10965, USA.
  • Tesfay MZ; Imanis Life Sciences, Rochester, MN 55902, USA.
  • Bomidi C; Imanis Life Sciences, Rochester, MN 55902, USA.
  • Hamm S; Profectus Biosciences, Inc., Pearl River, NY 10965, USA.
  • Vandergaast R; Imanis Life Sciences, Rochester, MN 55902, USA.
  • Jenks N; Toxicology and Pharmacology Laboratory, Mayo Clinic, Rochester, MN 55905, USA.
  • Steele MB; Toxicology and Pharmacology Laboratory, Mayo Clinic, Rochester, MN 55905, USA.
  • Ota-Setlik A; Profectus Biosciences, Inc., Pearl River, NY 10965, USA.
  • Akhtar H; Profectus Biosciences, Inc., Pearl River, NY 10965, USA.
  • Luckay A; Profectus Biosciences, Inc., Pearl River, NY 10965, USA.
  • Nowak R; Profectus Biosciences, Inc., Pearl River, NY 10965, USA.
  • Peng KW; Toxicology and Pharmacology Laboratory, Mayo Clinic, Rochester, MN 55905, USA.
  • Eldridge JH; Vyriad, Inc., Rochester, MN 55902, USA.
  • Clarke DK; Deparment of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
  • Russell SJ; Profectus Biosciences, Inc., Pearl River, NY 10965, USA.
  • Diaz RM; Profectus Biosciences, Inc., Pearl River, NY 10965, USA.
Mol Ther Oncolytics ; 10: 1-13, 2018 Sep 28.
Article em En | MEDLINE | ID: mdl-29998190

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article